Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.

Tiger Aesthetics Medical, LLC has announced the acquisition of nearly all assets from Sientra Inc.'s breast implant business. Echoing a strategic move to enhance their upcoming product lines in adipose cell and tissue treatments, this acquisition enables the incorporation of Sientra as a new division within Tiger Aesthetics Medical, LLC.

With this merger, the company aligns further into regenerative medicine and enhances their solutions offered to plastic surgeons and their patients. Oliver Burckhardt, Co-CEO of Tiger Aesthetics Medical, expressed excitement about integrating the Sientra brand, which involves merging surgical assets with tissue engineering expertise to innovate in augmentation and reconstructive surgery.

The continuity of operations and product quality at Sientra’s existing facilities in Franklin, WI, is highlighted as a priority for Tiger Aesthetics. Committing to uphold industry-standard warranty policies and ensuring a smooth transition for stakeholders marks critical steps in their strategic integration efforts.

Scott Madden, another Co-CEO at Tiger Aesthetics Medical, emphasized the potential in combined organizational strengths to drive advancements in patient care and reshape the aesthetics industry landscape.